Global Information
회사소개 | 문의 | 비교리스트

미국의 집단건강관리(PHM) 시장 : 제품별(소프트웨어, 서비스), 최종 용도별(프로바이더, 지불자, 고용자 그룹) 시장 규모, 점유율 및 동향 분석, 부문별 예측(2022-2030년)

U.S. Population Health Management Market Size, Share & Trends Analysis Report by Product (Software, Services), By End Use (Providers, Payers, Employer Groups), And Segment Forecasts, 2022 - 2030

리서치사 Grand View Research, Inc.
발행일 2022년 04월 상품코드 1044765
페이지 정보 영문 92 Pages 배송안내 2-10일 (영업일 기준)
가격
US $ 5,950 ₩ 7,581,000 Unprintable PDF (Single User License)
US $ 6,950 ₩ 8,855,000 Printable PDF (5-User License)
US $ 8,950 ₩ 11,404,000 Printable PDF (Enterprise License)


미국의 집단건강관리(PHM) 시장 : 제품별(소프트웨어, 서비스), 최종 용도별(프로바이더, 지불자, 고용자 그룹) 시장 규모, 점유율 및 동향 분석, 부문별 예측(2022-2030년) U.S. Population Health Management Market Size, Share & Trends Analysis Report by Product (Software, Services), By End Use (Providers, Payers, Employer Groups), And Segment Forecasts, 2022 - 2030
발행일 : 2022년 04월 페이지 정보 : 영문 92 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

미국의 집단건강관리(PHM) 시장 규모는 예측 기간 중 19.5%의 CAGR로 확대하며, 2030년에는 1,037억 달러에 달할 전망입니다.

의료비의 증가, 가치 기반 의료 제공의 필요성, 다른 의료 현장에서의 효과적인 질병 관리 등이 예측 기간 중 시장 성장을 촉진하는 주요 요인입니다.

미국의 집단건강관리(PHM) 시장에 대해 조사분석했으며, 시장 및 업계 전망, 부문별·지역별 시장의 전망 및 경쟁 구도에 관한 정보를 정리하여 전해드립니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 시장 변수, 동향, 범위

  • 시장 세분화
  • 시장 역학
  • 미국의 집단건강관리(PHM) 시장 : 비지니스 환경 분석 툴
  • 침투와 성장 전망 지도제작
  • 규제 시나리오와 상환 프레임워크
  • COVID-19 팬데믹의 영향 : 정성 분석

제4장 미국의 집단건강관리(PHM) 시장 : 제품별 분석

  • 미국의 집단건강관리(PHM) 제품별 시장 점유율 분석, 2020년 및 2028년
  • 미국의 집단건강관리(PHM) 제품별 시장 : 부문 대시보드
  • 제품별 부문 시장 규모와 예측 및 동향 분석, 2016-2028년

제5장 미국의 집단건강관리(PHM) 시장 : 최종 용도 분석

  • 미국의 집단건강관리(PHM) 최종 용도별 시장 점유율 분석, 2020년 및 2028년
  • 미국의 집단건강관리(PHM) 최종 용도별 시장 : 부문 대시보드
  • 최종 용도 부문 시장 규모와 예측 및 동향 분석, 2016-2028년

제6장 경쟁 분석

  • 전략적 프레임워크/경쟁 분류(주요 이노베이터, 시장 리더, 신규 기업)
  • 벤더 구도
    • 기업의 시장 현황 분석
  • 미국의 PHM 벤더 리스트
  • 주요 기업 개요
    • Allscripts Healthcare, LLC
    • Cerner Corporation
    • Conifer Health Solutions, LLC
    • eClinicalWorks
    • Enli Health Intelligence
    • McKesson Corporation
    • Medecision
    • Optum, Inc.
    • Advisory Board
    • Koninklijke Philips N.V.
    • athenahealth, Inc.
    • RedBrick Health Corporation
    • Welltok
KSA 22.01.25

List of Tables

  • 1. List of secondary sources
  • 2. List of abbreviation
  • 3. U.S. Population Health Management Market, by Product, 2017 - 2030 (USD Billion)
  • 4. U.S. Population Health Management Market, by End Use, 2017 - 2030 (USD Billion)

List of Figures

  • 1. U.S. population health management (PHM) market segmentation
  • 2. Market research process
  • 3. Information procurement
  • 4. Primary research pattern
  • 5. Market research approaches
  • 6. Value chain based sizing & forecasting
  • 7. QFD modelling for market share assessment
  • 8. Market formulation & validation
  • 9. U.S. population health management (PHM) market outlook, 2021 (USD Billion)
  • 10. Market trends & outlook
  • 11. Market driver relevance analysis (Current & future impact)
  • 12. Market restraint relevance analysis (Current & future impact)
  • 13. Penetration & growth prospect mapping
  • 14. U.S. Population Health Management (PHM) product market share analysis, (USD Billion)
  • 15. U.S. population health management (PHM) market: Product segment dashboard
  • 16. Software market, 2017 - 2030 (USD Billion)
  • 17. Services market, 2017 - 2030 (USD Billion)
  • 18. U.S. population health management (PHM) end use market share analysis, (USD Billion)
  • 19. U.S. population health management (PHM) market: End use segment dashboard
  • 20. Providers market, 2017 - 2030 (USD Billion)
  • 21. Payers market, 2017 - 2030 (USD Billion)
  • 22. Employer groups market, 2017 - 2030 (USD Billion)
  • 23. Impact analysis by key market participants
  • 24. Company/competition categorization
  • 25. Company market position analysis

U.S. Population Health Management Market Growth & Trends:

The U.S. population health management market size is expected to reach USD 103.7 billion in 2030, registering a CAGR of 19.5% from 2022 to 2030, according to a new report by Grand View Research, Inc. Increase in healthcare expenditure, need for value-based healthcare delivery, and effective disease management across different care settings are among the key factors expected to drive the market during the forecast period.

In the U.S., poor healthcare management results in the loss of productivity and a significant portion of healthcare costs. Adoption of PHM software by employers helps in the management of their healthcare budget as they can keep a track of the employees' health status. The market is likely to witness rapid growth in the coming years due to the growing demand for healthcare IT services and solutions that encourage healthcare delivery reliant on value, resulting in a transition from Fee-For-Service to a value-based payment model.

Population health management is built on a Fee-for-Service (FFS) reimbursement method, wherein physicians and other healthcare providers are reimbursed by government agencies and insurance companies on basis of the number of services offered to patients. The new payment model allows reimbursement based on the quality of care delivered and provides comprehensive tools to handle financial and clinical risk for value-based care delivery.

The COVID-19 pandemic has changed the outlook of healthcare in the U.S. with the advanced use of web-based technology in healthcare. Healthcare providers are increasingly investing in PHM software to offer better outcomes. PHM can also be used for tracking the vital signs of patients discharged from hospitals, which can then be analyzed to offer meaningful insights into a patient's health. The lockdown has disrupted the existing system and PHM systems are the current need to manage the patient population.

U.S. Population Health Management Market Report Highlights:

  • An increase in healthcare expenditure, the need for value-based healthcare delivery, and effective disease management across different care settings is expected to drive the market
  • The services segment dominated the global market in 2021, while the software segment is likely to register the fastest CAGR over the forecast period
  • The market is now shifting to a value-based payment model. The value-based contracts are expected to grow substantially in the coming years

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary research
  • 1.4 Information or Data Analysis
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity flow analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Research Objectives
    • 1.9.1 Objective - 1
    • 1.9.2 Objective - 2
    • 1.9.3 Objective - 3

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
    • 2.2.1 Product
    • 2.2.2 End Use
  • 2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Dynamics
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Growing demand for value-based healthcare delivery
      • 3.1.1.2 Rising healthcare expenditure
      • 3.1.1.3 Need for effective disease management across different care settings
      • 3.1.1.4 Rapidly aging population in the U.S.
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 Lack of proper regulatory framework for PHM
      • 3.1.2.2 High cost and challenges related to treatment model
  • 3.2 U.S. Population Health Management (PHM) Market: Business Environment Analysis Tools
    • 3.2.1 Porter's Five Forces Analysis
      • 3.2.1.1 Threat of new entrants: Moderate to High
      • 3.2.1.2 Threat of substitutes: High
      • 3.2.1.3 Competitive rivalry: High
      • 3.2.1.4 Bargaining power of suppliers: High
      • 3.2.1.5 Bargaining power of buyers: Low
    • 3.2.2 PESTEL Analysis
      • 3.2.2.1 Political & Legal
      • 3.2.2.2 Economic
      • 3.2.2.3 Technological
  • 3.3 Penetration & Growth Prospect Mapping
  • 3.4 Regulatory Scenario & Reimbursement Framework
  • 3.5 COVID-19 Pandemic Impact: Qualitative Analysis

Chapter 4 U.S. Population Health Management (PHM) Market: Product Analysis

  • 4.1 U.S. Population Health Management (PHM) Product Market Share Analysis, 2021 & 2030
  • 4.2 U.S. Population Health Management (PHM) Market: Product Segment Dashboard
  • 4.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Product Segment
    • 4.3.1 Software
      • 4.3.1.1 Software market, 2017 - 2030 (USD Billion)
    • 4.3.2 Services
      • 4.3.2.1 Services market, 2017 - 2030 (USD Billion)

Chapter 5 U.S. Population Health Management (PHM) Market: End Use Analysis

  • 5.1 U.S. Population Health Management (PHM) End Use Market Share Analysis, 2021 & 2030
  • 5.2 U.S. Population Health Management (PHM) Market: End Use Segment Dashboard
  • 5.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the End Use Segment
    • 5.3.1 Providers
      • 5.3.1.1 Providers market, 2017 - 2030 (USD Billion)
    • 5.3.2 Payers
      • 5.3.2.1 Payers market, 2017 - 2030 (USD Billion)
    • 5.3.3 Employer Groups
      • 5.3.3.1 Employer Groups market, 2017 - 2030 (USD Billion)

Chapter 6 Competitive Analysis

  • 6.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 6.2 Company/Competition Categorization
  • 6.3 Company Market Position Analysis
  • 6.4 List of Few PHM Vendors in the U.S.
  • 6.5 Company Profiles
    • 6.5.1 ALLSCRIPTS HEALTHCARE, LLC
      • 6.5.1.1 Company overview
      • 6.5.1.2 Financial performance
      • 6.5.1.3 Product benchmarking
      • 6.5.1.4 Strategic initiatives
    • 6.5.2 CERNER Corporation
      • 6.5.2.1 Company overview
      • 6.5.2.2 Financial performance
      • 6.5.2.3 Product benchmarking
      • 6.5.2.4 Strategic initiatives
    • 6.5.3 CONIFER HEALTH SOLUTIONS, LLC
      • 6.5.3.1 Company overview
      • 6.5.3.2 Financial performance
      • 6.5.3.3 Product benchmarking
      • 6.5.3.4 Strategic initiatives
    • 6.5.4 ECLINICALWORKS
      • 6.5.4.1 Company overview
      • 6.5.4.2 Financial performance
      • 6.5.4.3 Product benchmarking
      • 6.5.4.4 Strategic initiatives
    • 6.5.5 Cedar Gate Technologies
      • 6.5.5.1 Company overview
      • 6.5.5.2 Financial performance
      • 6.5.5.3 Product benchmarking
      • 6.5.5.4 Strategic initiatives
    • 6.5.6 MCKESSON CORPORATION
      • 6.5.6.1 Company overview
      • 6.5.6.2 Financial performance
      • 6.5.6.3 Product benchmarking
      • 6.5.6.4 Strategic initiatives
    • 6.5.7 MEDECISION
      • 6.5.7.1 Company overview
      • 6.5.7.2 Financial performance
      • 6.5.7.3 Product benchmarking
      • 6.5.7.4 Strategic initiatives
    • 6.5.8 OPTUM, INC.
      • 6.5.8.1 Company overview
      • 6.5.8.2 Financial performance
      • 6.5.8.3 Product benchmarking
      • 6.5.8.4 Strategic initiatives
    • 6.5.9 ADVISORY BOARD
      • 6.5.9.1 Company overview
      • 6.5.9.2 Financial performance
      • 6.5.9.3 Strategic initiatives
    • 6.5.10 KONINKLIJKE PHILIPS N.V.
      • 6.5.10.1 Company overview
      • 6.5.10.2 Financial performance
      • 6.5.10.3 Product benchmarking
      • 6.5.10.4 Strategic initiatives
    • 6.5.11 ATHENAHEALTH, INC.
      • 6.5.11.1 Company overview
      • 6.5.11.2 Financial performance
      • 6.5.11.3 Product benchmarking
      • 6.5.11.4 Strategic initiatives
    • 6.5.12 REDBRICK HEALTH CORPORATION
      • 6.5.12.1 Company overview
      • 6.5.12.2 Financial performance
      • 6.5.12.3 Product benchmarking
      • 6.5.12.4 Strategic initiatives
    • 6.5.13 WELLTOK
      • 6.5.13.1 Company overview
      • 6.5.13.2 Financial performance
      • 6.5.13.3 Product benchmarking
      • 6.5.13.4 Strategic initiatives
Back to Top
전화 문의
F A Q